- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions

European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
Pharmaceuticals - Community Register
Community list of not active orphan medicinal products |
WITHDRAWN |
Product information |
Lintuzumab
EU orphan designation number: | EU/3/09/626 |
Active ingredient: | Lintuzumab |
Indication: | Treatment of myelodysplastic syndromes |
Sponsor: | Seattle Genetics UK Limited
c/o Jordans Limited, 20-22 Bedford Row, London WC1R 4JS , United Kingdom |
Public summary of scientific opinion
European Commission procedures |